The Medicamen Biotech share price forecast for the next 3 years points to a scenario range of Rs 260 to Rs 425 by 2030, driven by rising export demand for its formulation portfolio and sector tailwinds.

UTI Long Term Advantage Fund Series III vs Sundaram Series IV Regular IDCW Payout: full NAV, returns and maturity status comparison based on official AMFI data.

The Munjal Auto Industries share price forecast for the next 3 years points to a scenario range of Rs 110 to Rs 185 by 2030, driven by rising two wheeler production and content per vehicle from sheet metal and exhaust components and sector tailwinds.

The N. B. I. Industrial Finance Company share price forecast for the next 3 years points to a scenario range of Rs 2,300 to Rs 3,800 by 2030, driven by any growth in its lending book and investment portfolio and sector tailwinds.

Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 2 Direct IDCW: full NAV, returns and maturity status comparison based on official AMFI data.

UTI Long Term Advantage Fund Series III vs ICICI Prudential R.I.G.H.T. Growth: full NAV, returns and maturity status comparison based on official AMFI data.

The Meghmani Organics share price forecast for the next 3 years points to a scenario range of Rs 55 to Rs 91 by 2030, driven by rising export demand for agrochemical and pigment products and capacity utilisation improvement and sector tailwinds.

The Mufin Green Finance share price forecast for the next 3 years points to a scenario range of Rs 140 to Rs 230 by 2030, driven by rising EV adoption in India driving demand for electric vehicle financing and sector tailwinds.

The Mukand share price forecast for the next 3 years points to a scenario range of Rs 180 to Rs 305 by 2030, driven by rising auto and industrial demand for specialty and alloy steel products and sector tailwinds.